| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Finance and CAO | Interim CFO | SVP, Finance and CAO +1 more
1 company
Shelly Wong is SVP, Finance and CAO at ALXO. Shelly Wong's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $113K at current prices.
Historically, Shelly Wong's trades have earned a middling insider score of 69/100 across 18 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +7.6%.
The ALXO filings lean toward selling, a net 32,122 shares.
Shelly Wong has 31 Form 4 filings on record from May 2021 to August 2026, all as SVP, Finance and CAO at ALX Oncology (ALXO), 2021–2026.
The 34 reported transactions were 19 open-market sales, 10 option or other derivative awards and 5 stock awards.
Counted by filing, the open-market trades come to no purchases and 19 sales worth about $158K.
The largest open-market sale was 7,345 shares of ALXO at an average $6.52 on July 6, 2023, about $48K. Twelve months later ALXO was down 14%.
None of the 18 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | ALXO Alx Oncology Holdings Inc. | SVP, Finance and CAO | Sell | 573 | $1.93 | $1,105.89 | -0.6% | - | - | |
| Jul 1, 2026 | ALXO Alx Oncology Holdings Inc. | SVP, Finance and CAO | Sell | 1,404 | $2.04 | $2,864.16 | -1.6% | -34.5% | - | |
| Mar 19, 2026 | ALXO Alx Oncology Holdings Inc. | SVP, Finance and CAO | Sell | 903 | $2.17 | $1,959.51 | -1.0% | -33.8% | - | |
| Feb 18, 2026 | ALXO Alx Oncology Holdings Inc. | SVP, Finance and CAO | Sell | 565 | $2.27 | $1,282.55 | -0.6% | -15.5% | - | |
| Jan 6, 2026 | ALXO Alx Oncology Holdings Inc | SVP, Finance and CAO | Sell | 3,925 | $1.11 | $4,356.75 | -4.3% | +81.5% | - | |
| Aug 15, 2025 | ALXO Alx Oncology Holdings Inc | SVP, Finance and CAO | Sell | 611 | $0.64 | $391.28 | -0.7% | +89.4% | +204.2% | |
| Jul 7, 2025 | ALXO Alx Oncology Holdings Inc | SVP, Finance and CAO | Sell | 2,011 | $0.45 | $905.15 | -2.3% | +375.2% | +431.5% | |
| Jun 30, 2025 | ALXO Alx Oncology Holdings Inc | SVP, Finance and CAO | Sell | 1,532 | $0.43 | $658.76 | -1.7% | +321.6% | +398.7% | |
| Feb 19, 2025 | ALXO Alx Oncology Holdings Inc | SVP, Finance and CAO | Sell | 550 | $1.15 | $632.61 | -0.6% | -64.0% | +118.5% | |
| Jan 6, 2025 | ALXO Alx Oncology Holdings Inc | Interim CFO | Sell | 2,221 | $1.80 | $3,997.80 | -2.5% | -70.1% | -39.7% |